Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays
Cambridge University Hospitals NHS Foundation Trust
Get tenders like this by email
New tenders like this one, in your inbox every morning. Starts with 14 days of Pro, no card needed.
Unsubscribe in one click. See our privacy policy.
Key details
Procurement
- 38950000 Polymerase Chain Reaction (PCR) equipment
Description
The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response.
We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.
How to engage
The Authority conducted a preliminary market engagement with the following companies to understand the available market options with loan instruments to complete the proof of concept runs. Indicative pricings were also obtained in the engagement process. The engagement companies were: - Bio-Rad Laboratories, Inc. - Qiagen N.V. - Thermo Fisher Scientific Inc.
Contact
Bid documents
Track this tender with a free account to open its bid documents.
Identifiers
Explore related tenders
Similar live tenders
Other tenders from Cambridge University Hospitals NHS Foundation Trust
View all →External ID: fts-ocds-h6vhtk-07b3e7 • Added 5 November 2026